Identifying microorganisms using three-dimensional quantitative phase imaging

    公开(公告)号:US12001940B2

    公开(公告)日:2024-06-04

    申请号:US17951872

    申请日:2022-09-23

    Applicant: Tomocube, Inc.

    CPC classification number: G06N3/045 G06T7/0012 G06T2207/10056

    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for identifying the predicted type of one or more microorganisms. In one aspect, a system comprises a phase-contrast microscope and a microorganism classification system. The phase-contrast microscope is configured to generate a three-dimensional quantitative phase image of one or more microorganisms. The microorganism classification system is configured to process the three-dimensional quantitative phase image using a neural network to generate a neural network output characterizing the microorganisms, and thereafter identify the predicted type of the microorganisms using the neural network output.

    Method and apparatus for rapid diagnosis of hematologic malignancy using 3D quantitative phase imaging and deep learning

    公开(公告)号:US11410304B2

    公开(公告)日:2022-08-09

    申请号:US16900364

    申请日:2020-06-12

    Applicant: TOMOCUBE, INC.

    Abstract: A non-label diagnosis apparatus for a hematologic malignancy may include a 3-D refractive index cell imaging unit configured to generate a 3-D refractive index slide image of a blood smear specimen by capturing a 3-D refractive index image in the form of the blood smear specimen in which blood (including a bone-marrow or other body fluids) of a patient has been smeared on a slide glass, an ROI detection unit configured to sample a suspected cell segment in the blood smear specimen based on the 3-D refractive index slide image and to determine, as ROI patches, cells determined as abnormal cells, and a diagnosis unit configured to determine a sub-classification of a cancer cell corresponding to each of the ROI patches using a cancer cell sub-classification determination model constructed based on a deep learning algorithm and to generate hematologic malignancy diagnosis results by gathering sub-classification results of the ROI patches.

Patent Agency Ranking